Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Fig. 2

Myeloid-specific targets as immune adjuncts for the management of solid malignancies. Targets were categorized based on their functional role: proliferation, differentiation, recruitment, polarization, functional blockade, cytokine signaling, epigenetic reprogramming, and metabolic reprograming. For cellular therapies, myeloid-specific approaches include dendritic cell vaccines and chimeric antigen receptor macrophages

Back to article page